NMIBC
Clinical trials for NMIBC explained in plain language.
Never miss a new study
Get alerted when new NMIBC trials appear
Sign up with your email to follow new studies for NMIBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot for bladder tumors shows promise in early trial
Disease control Recruiting nowThis early-stage study is testing a new drug, belzupacap sarotalocan, injected directly into bladder tumors to see if it's safe and doable for people with non-muscle-invasive bladder cancer. About 55 participants will receive the injection, sometimes with a laser, and be monitore…
Matched conditions: NMIBC
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
New bacterial therapy could change bladder cancer care
Disease control Recruiting nowThis study tests a new treatment for non-muscle invasive bladder cancer (NMIBC) using a modified version of the BCG bacteria, given directly into the bladder. It is for adults who have not had BCG before and have certain types of bladder tumors. The goal is to see if the treatmen…
Matched conditions: NMIBC
Phase: PHASE1, PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 17, 2026 05:28 UTC
-
New hope for bladder cancer patients unable to join trials
Disease control AVAILABLEThis program provides a genetically modified version of the standard BCG treatment to people with non-muscle invasive bladder cancer who are not able to join a clinical trial. It is for adults aged 18 and older with high-grade transitional cell carcinoma. The goal is to offer a p…
Matched conditions: NMIBC
Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC